Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection

Tuberculosis (TB) remains a leading global cause of morbidity and mortality and an effective new vaccine is urgently needed. A major barrier to the rational development of novel TB vaccines is the lack of a validated immune correlate or biomarker of protection. Mycobacterial Growth Inhibition Assays...

Cijeli opis

Bibliografski detalji
Glavni autori: Rachel Tanner, Iman Satti, Stephanie A. Harris, Matthew K. O'Shea, Deniz Cizmeci, Daniel O'Connor, Agnieszka Chomka, Magali Matsumiya, Rachel Wittenberg, Angela M. Minassian, Joel Meyer, Helen A. Fletcher, Helen McShane
Format: Članak
Jezik:English
Izdano: Frontiers Media S.A. 2020-01-01
Serija:Frontiers in Immunology
Teme:
Tuberculosis
vaccine
BCG
mycobacterial growth inhibition assay
MGIA
Online pristup:https://www.frontiersin.org/article/10.3389/fimmu.2019.02983/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.02983/full

Slični predmeti